New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 25, 2019 - Bausch Health announced the FDA approval of Duobrii (halobetasol propionate and tazarotene) lotion, for the topical treatment of plaque psoriasis in adults.
Download PDF
Return to publications
